Kristina Beeler serves as Chief Business Officer at Biognosys, a leader in next-generation proteomics, dedicated to transforming life science by inventing and developing cutting-edge proteomics technology and solutions and making them widely available for pharmaceutical and biotechnology researchers. Kristina leads the business activities of Biognosys’ portfolio of proprietary proteomics services that provide a multi-dimensional view of protein expression, function, and structure with industry-leading precision, depth, and throughput. Her team enables Biognosys’ global partners to utilize proteomics to address the key challenges in their research. Before joining Biognosys, Kristina gained experience in biotech evaluation and investing in her function as Principal at Nextech Invest, a Swiss-based venture capital firm focused on identifying transformative cancer medicines and investing in emerging biotechnology companies. Kristina has a strong scientific background in immunology and oncology, which she obtained during her Master Studies at the University of Oxford and her Doctoral Studies at the University of Zurich.